Medication info
Ibeoro Tablet 150 mg (Irbesartan)

Ibeoro Tablet 150 mg (Irbesartan)

Prescription medicationTabletOral
Ingredient · strength
Irbesartan›150mg
Manufacturer / importer
KMS Pharmaceutical Co., Ltd.
Appearance
White or almost white, biconvex, oval tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200800296 · Notified 2008.01.08 · Insurance code 654701180

Summary

Main use
Treatment of essential hypertension and nephropathy in patients with type 2 diabetes mellitus accompanied by hypertension
Who takes it
Adults
Adult dose
This drug may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan 150 mg orally once daily; the dose may be increased to 300 mg if the effect is insufficient. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily, but 75 mg may be considered in certain circumstances (such as at the start of treatment, in patients on hemodialysis, or in elderly patients aged 75 years or older). If blood pressure control is inadequate with monotherapy, another antihypertensive may be administered concomitantly. The effect is increased, particularly when administered with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Kidney disease in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with 150 mg of this drug once daily and increase to 300 mg for maintenance. If necessary, another antihypertensive may be administered concomitantly to achieve the target blood pressure. ○ Elderly patients Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in elderly patients aged 75 years or older. ○ Patients with renal impairment Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients on hemodialysis. ○ Patients with hepatic impairment No specific dosage adjustment is generally necessary in patients with mild to moderate hepatic impairment, but it is recommended that the dose not exceed 150 mg per day. However, there is no clinical experience in patients with severe hepatic impairment.

Ingredients

Manufacturer
KMS Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and nephropathy in patients with type 2 diabetes mellitus accompanied by hypertension

  • Essential hypertension
  • hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used to control blood pressure in patients with essential hypertension. It is also prescribed for preventing and managing kidney disease in patients with type 2 diabetes who require treatment for hypertension. Therefore, it helps stabilize blood pressure and prevent deterioration of kidney function.

How to take

Adult dose

This drug may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan 150 mg orally once daily; the dose may be increased to 300 mg if the effect is insufficient. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily, but 75 mg may be considered in certain circumstances (such as at the start of treatment, in patients on hemodialysis, or in elderly patients aged 75 years or older). If blood pressure control is inadequate with monotherapy, another antihypertensive may be administered concomitantly. The effect is increased, particularly when administered with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Kidney disease in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with 150 mg of this drug once daily and increase to 300 mg for maintenance. If necessary, another antihypertensive may be administered concomitantly to achieve the target blood pressure. ○ Elderly patients Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in elderly patients aged 75 years or older. ○ Patients with renal impairment Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients on hemodialysis. ○ Patients with hepatic impairment No specific dosage adjustment is generally necessary in patients with mild to moderate hepatic impairment, but it is recommended that the dose not exceed 150 mg per day. However, there is no clinical experience in patients with severe hepatic impairment.

Precautions

This medication can cause serious harm to the fetus during pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Patients with allergic reactions to this medication, severe liver dysfunction, hereditary angioedema, women who may become pregnant, or those who are breastfeeding should not take it. Patients with impaired liver function, elderly patients, and those with hyperkalemia should use this medication with caution and be carefully monitored to avoid excessively low blood pressure. As this is a medication that lowers blood pressure, side effects such as hypotension, dizziness, and fatigue may occur, particularly during initial use of the medication. This medication may increase serum potassium levels, so caution should be taken when used in combination with potassium supplements or potassium-sparing diuretics. Patients with impaired renal function or diabetic kidney disease should have their renal function and serum potassium levels monitored regularly. During the use of this medication, serious side effects such as liver function abnormalities, angioedema, severe hypotension, renal failure, hypoglycemia, and rhabdomyolysis may occur, so any unusual symptoms should prompt immediate consultation with a physician. Interactions may occur with other antihypertensive medications, diuretics, non-steroidal anti-inflammatory drugs (NSAIDs), and lithium; therefore, it is essential to inform the healthcare provider of any co-administered medications. Caution is needed as dizziness or fatigue may occur while driving or operating machinery. Safety in pediatric patients has not been established, and elderly patients should generally start at low doses and be treated with caution. In cases of overdose, symptoms such as hypotension or tachycardia may appear, necessitating an immediate visit to a medical institution for appropriate treatment. This medication should be stored out of the reach of children and should not be transferred to other containers for safety.

Side effects

  • Respiratory infection
  • headache
  • musculoskeletal pain
  • dizziness
  • fatigue
  • diarrhea
  • cough
  • nausea/vomiting
  • musculoskeletal injury
  • chest pain
Show 101 more
  • dyspepsia/heartburn
  • edema
  • abdominal pain
  • rash
  • tachycardia
  • anxiety/nervousness
  • upper urinary tract infection
  • fever
  • chills
  • facial swelling
  • arm swelling
  • flushing
  • hypertension
  • heart murmur
  • myocardial infarction
  • angina
  • arrhythmia/conduction abnormality
  • cardiac-respiratory arrest
  • heart failure
  • hypertensive crisis
  • itching
  • dermatitis
  • petechiae
  • erythema
  • hives
  • sexual dysfunction
  • changes in sexual function
  • gout
  • constipation
  • oral lesions
  • gastroenteritis
  • abdominal distension
  • limb edema
  • muscle spasm
  • arthritis
  • myalgia
  • chest pain
  • joint stiffness
  • bursitis
  • muscle weakness
  • sleep disorders
  • paralysis
  • somnolence
  • emotional disorders
  • depression
  • sensory disturbances
  • tremors
  • transient ischemia
  • cerebrovascular accident
  • abnormal urination
  • prostate disorders
  • nasal bleeding
  • bronchitis
  • congestion
  • pulmonary congestion
  • dyspnea
  • wheezing
  • visual disturbances
  • auditory disturbances
  • otitis
  • ear pain
  • conjunctivitis
  • eyelid abnormalities
  • ear abnormalities
  • dizziness
  • orthostatic dizziness
  • orthostatic hypotension
  • increased plasma creatine kinase
  • hyperkalemia
  • hypersensitivity reactions
  • rash
  • hives
  • angioedema
  • anaphylactic shock
  • anaphylactic reaction
  • weakness
  • diarrhea
  • dyspepsia
  • nausea
  • tinnitus
  • myalgia
  • increased plasma creatine kinase
  • arthralgia
  • tachycardia
  • hepatitis
  • liver dysfunction
  • renal failure
  • renal impairment
  • psoriasis
  • photosensitivity reaction
  • anemia
  • thrombocytopenia
  • hypoglycemia
  • angioedema
  • shock
  • syncope
  • loss of consciousness
  • renal failure
  • liver dysfunction
  • jaundice
  • rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, ideally in a cool and dry place below 30 degrees Celsius.

Appearance and packaging

Appearance

White or almost white, biconvex, oval tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.